Immucell ICCC
NASDAQ ICCC
$10.52 +0.07 (+0.67%)
At close: Oct 21, 2026 · 4:00 PM EDT

Immucell (ICCC) Times Interest Earned (2023 - 2026)

Updated

Immucell's (ICCC) Times Interest Earned was 20.23 for Q2 2026, up 343.2% from 4.56 a year earlier.

Analysis

Immucell (ICCC) Times Interest Earned (2023 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Immucell's Times Interest Earned came in at 5.35, up 68.9% year-over-year; for FY2025, it came in at 3.34.

  • By year, Times Interest Earned came in at -2.88 in FY2024, -12.09 in FY2023 and -6.60 in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly Times Interest Earned in data going back to Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.41
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 10.28
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 7.27
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 5.22
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -42.08
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Immucell 95.91 Mn 73.35 Mn 2.44 Mn 20.23
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.23
Dec 31, 2025 -0.55
Sep 30, 2025 0.15
Jun 30, 2025 4.56
Dec 31, 2024 4.56
Sep 30, 2024 -3.99
Jun 30, 2024 -9.74
Mar 31, 2024 -2.06
Jun 30, 2023 -14.73
Mar 31, 2023 -25.07
API Access

Immucell Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=ICCC&period=max&api_key=YOUR_API_KEY